These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17952254)

  • 1. [Hormone replacement therapy and endometrial cancer].
    Araújo NL; Athanazio DA
    Cad Saude Publica; 2007 Nov; 23(11):2613-22. PubMed ID: 17952254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
    Roy JA; Sawka CA; Pritchard KI
    J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and the endometrium.
    Daayana S; Holland CM
    Menopause Int; 2009 Sep; 15(3):134-8. PubMed ID: 19723685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Jan; 35(1):1-16. PubMed ID: 7751408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Mar; 35(3):314-29. PubMed ID: 7608324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.
    Fournier A; Dossus L; Mesrine S; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
    Am J Epidemiol; 2014 Sep; 180(5):508-17. PubMed ID: 25008104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone replacement therapy: endometrial and breast effects.
    Yeh IT
    Adv Anat Pathol; 2007 Jan; 14(1):17-24. PubMed ID: 17198307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
    Comerci JT; Fields AL; Runowicz CD; Goldberg GL
    Gynecol Oncol; 1997 Mar; 64(3):425-30. PubMed ID: 9062144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
    Beresford SA; Weiss NS; Voigt LF; McKnight B
    Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of menopause in women with a history of endometriosis: a systematic review.
    Gemmell LC; Webster KE; Kirtley S; Vincent K; Zondervan KT; Becker CM
    Hum Reprod Update; 2017 Jul; 23(4):481-500. PubMed ID: 28498913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.